Manpowergroup Inc.
$4.28B- Market cap
- $2.88B
- Debt
- +$2.27B
- Cash
- −$871.00M
Capital structure 56% equity / 44% debt · EV / Revenue 0.24x · EV / EBITDA 33.75x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: MAN stock price at discount vs DGX $61.98 current versus $915.86 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DGX's multiple
Implied fair value · at MAN's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MAN FY 2025 (ended Dec 31, 2025) · DGX FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 56% equity / 44% debt · EV / Revenue 0.24x · EV / EBITDA 33.75x
Capital structure 81% equity / 19% debt · EV / Revenue 2.89x · EV / EBITDA 14.81x
DGX carries the larger enterprise value at $31.93B against $4.28B; MAN trades on the lower EV / Revenue multiple (0.24x vs 2.89x); DGX on the lower EV / EBITDA (14.81x vs 33.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MANPOWERGROUP INC. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Quest Diagnostics Inc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.10x
0.86x
Net debt / EBITDA
Leverage against operating earnings
11.01x
2.67x
Cash and equivalents
Liquid reserves on the balance sheet
$871.00M
$420.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ROBERT HALF INC.
MAN vs RHI
KFORCE INC
MAN vs KFRC
INSPERITY, INC.
MAN vs NSP
KELLY SERVICES INC
MAN vs KELYA
ABBOTT LABORATORIES
MAN vs ABT
DANAHER CORP /DE/
MAN vs DHR
THERMO FISHER SCIENTIFIC INC.
MAN vs TMO
HCA Healthcare, Inc.
MAN vs HCA
LABCORP HOLDINGS INC.
MAN vs LH
WEST PHARMACEUTICAL SERVICES INC
MAN vs WST
$2.27B
$6.18B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.